Glaxo to make public educational, charitable grants
GlaxoSmithKline will proactively report educational and charitable grants provided to health-related organizations in the U.S., beginning in February 2009.
The London-based pharmaceutical company announced the decision as members of Congress have been urging pharmaceutical and medical device companies to provide more public information about their grant-giving activities.
Glaxo said reports will be updated on a quarterly basis to include grants that are provided to organizations including hospitals, teaching institutions, managed-care companies, professional associations, patient advocacy groups and continuing medical education (CME) companies.
In a similar but more dramatic move, Pfizer last month reported that it was eliminating all direct funding for any new physician CME programs provided by medical education and communication companies.
The London-based pharmaceutical company announced the decision as members of Congress have been urging pharmaceutical and medical device companies to provide more public information about their grant-giving activities.
Glaxo said reports will be updated on a quarterly basis to include grants that are provided to organizations including hospitals, teaching institutions, managed-care companies, professional associations, patient advocacy groups and continuing medical education (CME) companies.
In a similar but more dramatic move, Pfizer last month reported that it was eliminating all direct funding for any new physician CME programs provided by medical education and communication companies.